Webinar
                            
                                Method Evaluation
                        CLSI EP43 Webinar
Implementing a Laboratory Test Under Emergency Use Conditions
Tune in to this on-demand webinar to learn about:
- Best practices for implementation based on EP19?A Framework for Using CLSI Documents to Evaluate Clinical Laboratory Measurement Procedures.
 - Understand the use of Emergency Use Authorization (EUA) during a Public Health Emergency (PHE) and non-US equivalents.
 - Show examples from both Ebola and COVID-19 (SARS-CoV-2).
 
This webinar is included as a free CLSI membership benefit.
 
                                            
                                        October 19, 2021
                                    
                            {{FormatPrice(currentPrice)}}
Free
{{FormatPrice(nonMemberPrice)}} List PriceThis is your member pricing.
                            
                            
                                Notify Me About New Editions
                        Scope
                                Learning Objectives
At the conclusion of this on-demand webinar, the learner will:
- Describe the use of Emergency Use Authorization (EUA) during a Public Health Emergency (PHE).
 - Explain the ways the Test Life Phases Model (CLSI EP19) can be applied to implementing an assay granted EUA.
 - Discuss how implementation of an EUA may differ from implementation of a cleared/approved test.
 - Identify some of the unique challenges in implementation of an EUA.
 
Scope
                                    Learning Objectives
At the conclusion of this on-demand webinar, the learner will:
- Describe the use of Emergency Use Authorization (EUA) during a Public Health Emergency (PHE).
 - Explain the ways the Test Life Phases Model (CLSI EP19) can be applied to implementing an assay granted EUA.
 - Discuss how implementation of an EUA may differ from implementation of a cleared/approved test.
 - Identify some of the unique challenges in implementation of an EUA.